Cargando…
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease
The use of infliximab has completely changed the therapeutic landscape in inflammatory bowel disease. However, despite its proven efficacy to induce and maintain clinical remission, increasing evidence suggests that treatment failure may be associated with inadequate drug blood concentrations. The i...
Autores principales: | Curci, Debora, Lucafò, Marianna, Parisse, Pietro, Decorti, Giuliana, Bramuzzo, Matteo, Casalis, Loredana, Stocco, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225523/ https://www.ncbi.nlm.nih.gov/pubmed/35743733 http://dx.doi.org/10.3390/jpm12060948 |
Ejemplares similares
-
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021) -
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021) -
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021) -
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021) -
A Validated HPLC–Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside
por: Franzin, Martina, et al.
Publicado: (2022)